Blend Labs, Inc. (NYSE:BLND – Get Free Report) insider Oxana Tkach sold 4,303 shares of the firm’s stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of $3.98, for a total transaction of $17,125.94. Following the sale, the insider now owns 88,651 shares of the company’s stock, valued at approximately $352,830.98. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Blend Labs Price Performance
NYSE BLND opened at $4.03 on Friday. The company has a market cap of $1.02 billion, a P/E ratio of -6.95 and a beta of 1.15. The stock has a 50-day moving average of $3.47 and a two-hundred day moving average of $2.97. Blend Labs, Inc. has a 1-year low of $1.10 and a 1-year high of $4.25.
Blend Labs (NYSE:BLND – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.04. The firm had revenue of $40.48 million for the quarter, compared to the consensus estimate of $39.50 million. Blend Labs had a negative net margin of 77.63% and a negative return on equity of 595.99%. On average, analysts anticipate that Blend Labs, Inc. will post -0.27 EPS for the current fiscal year.
Institutional Trading of Blend Labs
Wall Street Analyst Weigh In
BLND has been the subject of several recent analyst reports. William Blair raised Blend Labs from a “market perform” rating to an “outperform” rating in a research note on Friday, August 9th. Canaccord Genuity Group raised Blend Labs from a “hold” rating to a “buy” rating and raised their price objective for the stock from $3.00 to $4.75 in a research report on Monday, August 12th. Canaccord Genuity Group raised shares of Blend Labs from a “hold” rating to a “buy” rating and upped their target price for the company from $3.00 to $4.75 in a research report on Monday, August 12th. Keefe, Bruyette & Woods lifted their price target on shares of Blend Labs from $3.00 to $3.25 and gave the company a “market perform” rating in a research report on Monday, August 12th. Finally, The Goldman Sachs Group upped their price objective on shares of Blend Labs from $3.00 to $3.40 and gave the stock a “buy” rating in a report on Friday, August 9th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $3.93.
Check Out Our Latest Stock Report on Blend Labs
About Blend Labs
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Featured Articles
- Five stocks we like better than Blend Labs
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Is Viking Therapeutics Ready For Another Surge?
- What Are Dividend Achievers? An Introduction
- AI Boom and Rate Cuts Boost Utility Stocks: Best Growth Picks
- 10 Best Airline Stocks to Buy
- Top 3 Homebuilder Stocks to Watch as Rates Drop
Receive News & Ratings for Blend Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blend Labs and related companies with MarketBeat.com's FREE daily email newsletter.